Panel Discussion – HDAC3, BET, RNA, So Many Targets – Exploring New Potential in Well Known Targets to Create New Value & Diversify Pipelines

Time: 9:30 am
day: Day One


  • Discuss disease positioning and the importance of this in creating value out of your existing IP
  • Highlight the criteria you should consider before exploring a new therapeutic area
  • Explore current examples of therapeutics that have been reused in this way
  • How can this potential be capitalized on for both oncological and non-oncological indications? Dr. Nikhil